BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 23166905)

  • 1. Inflammatory bowel disease: a Canadian burden of illness review.
    Rocchi A; Benchimol EI; Bernstein CN; Bitton A; Feagan B; Panaccione R; Glasgow KW; Fernandes A; Ghosh S
    Can J Gastroenterol; 2012 Nov; 26(11):811-7. PubMed ID: 23166905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.
    Kaplan GG; Bernstein CN; Coward S; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S6-S16. PubMed ID: 31294381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort.
    Lo B; Vind I; Vester-Andersen MK; Bendtsen F; Burisch J
    J Crohns Colitis; 2020 Jan; 14(1):53-63. PubMed ID: 31076743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of illness analysis of inflammatory bowel disease.
    Pakdin M; Zarei L; Bagheri Lankarani K; Ghahramani S
    BMC Gastroenterol; 2023 Jan; 23(1):21. PubMed ID: 36658489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ECONOMIC BURDEN AND CURRENT STATUS OF THE DRUG SUPPLY MANAGEMENT FOR IMMUNE INFLAMMATORY DISEASES (BY EXAMPLE OF ULCERATIVE COLITIS AND CROHN'S DISEASE)].
    Veselov AV; Belousova EA; Bakulin IG; Uspenskiy YP; Dreval RO; Shkurko TV; Kashnikov BN; Fominykh YA; Knyazev OV; Romanov RI; Skalinskaia MI; Shipitsyn VV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2020 Oct; 28(Special Issue):1137-1145. PubMed ID: 33219771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of Illness in Inflammatory Bowel Disease.
    Kamat N; Ganesh Pai C; Surulivel Rajan M; Kamath A
    Dig Dis Sci; 2017 Sep; 62(9):2318-2326. PubMed ID: 28766243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report: economic implications of inflammatory bowel disease and its management.
    Mehta F
    Am J Manag Care; 2016 Mar; 22(3 Suppl):s51-60. PubMed ID: 27269903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review.
    El-Matary W; Kuenzig ME; Singh H; Okoli G; Moghareh M; Kumar H; Lê ML; Benchimol EI
    Inflamm Bowel Dis; 2020 Jan; 26(2):206-215. PubMed ID: 31211827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.
    Bassi A; Dodd S; Williamson P; Bodger K
    Gut; 2004 Oct; 53(10):1471-8. PubMed ID: 15361497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of inflammatory bowel disease in Canada: a population-based study.
    Bernstein CN; Wajda A; Svenson LW; MacKenzie A; Koehoorn M; Jackson M; Fedorak R; Israel D; Blanchard JF
    Am J Gastroenterol; 2006 Jul; 101(7):1559-68. PubMed ID: 16863561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Tan MC; El-Serag HB; Hou JK
    Dig Dis Sci; 2017 Mar; 62(3):607-614. PubMed ID: 28012103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.